Get started
Author

Luke Burman

Observed names: L Burman, L. Burman, Luke G. Burman
ORCID: 0000-0002-8758-8120
Observed ORCID: 0000-0002-8758-8120
OpenAlex ID: A5009355300
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer
2023 · Zhiwen Xu, Hira Lal Goel, et al. · Science Translational Medicine · 49
PDF
Analysis of rRNA processing and translation in mammalian cells using a synthetic 18S rRNA expression system
2012 · Luke G. Burman, Vincent P. Mauro · Nucleic Acids Research · 20
The 5′ Leader of the mRNA Encoding the Marek's Disease Virus Serotype 1 pp14 Protein Contains an Intronic Internal Ribosome Entry Site with Allosteric Properties
2009 · Abdessamad Tahiri-Alaoui, Daiki Matsuda, et al. · Journal of Virology · 17
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis
2025 · Leslie A. Nangle, Zhiwen Xu, et al. · Science Translational Medicine · 16
Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants
2020 · Luke Burman, Yeeting E. Chong, et al. · mAbs · 11
Development and Characterization of a Novel Neuropilin-2 Antibody for Immunohistochemical Staining of Cancer and Sarcoidosis Tissue Samples
2023 · Sarah Förster, Yeeting E. Chong, et al. · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · 7
ATYR1923 Specifically Binds to Neuropilin-2, a Novel Therapeutic Target for the Treatment of Immune-Mediated Diseases
2020 · Z. Xu, Y. Chong, et al. · American Journal of Respiratory and Critical Care Medicine · 2
A novel neuropilin-2 (NRP2) antibody for immunohistochemical staining of patient tissue samples
2022 · Y Chong, S Förster, et al. · European Respiratory Journal · 1
Abstract LB095: A domain-specific antibody to NRP2 down-regulated epithelial-mesenchymal transition genes and enhanced efficacy of standard-of-care therapeutics for aggressive breast cancer
2021 · Zhiwen Xu, Christoph Burkart, et al. · Cancer Research · 1
Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis
2026 · Ryan A. Adams, Ying-Ting Wang, et al. · Journal of Biological Chemistry
A bispecific antibody designed to act as a NRP2/PLXNA1 agonist mimics anticancer activity of SEMA3F
2025 · Honglei Tian, Chun Po Fung, et al. · Journal of Biological Chemistry
Targeting VEGF/Neuropilin-2 as a Novel Approach to Induce Radiosensitivity in Triple Negative Breast Cancer
2023 · A. Kumar, H.L. Goel, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Efzofitimod, a Novel Immunomodulator for Pulmonary Sarcoidosis, Modulates Patient Inflammatory Responses Through Myeloid Cells
2023 · D. Siefker, S. Paz, et al. · American Journal of Respiratory and Critical Care Medicine
Abstract LB085: ATYR2810, a fully humanized monoclonal antibody targeting the VEGF-NRP2 pathway sensitizes highly aggressive and chemoresistant TNBC subtypes to chemotherapy
2022 · Zhiwen Xu, Alison Barber, et al. · Cancer Research
Abstract 1785: Domain-specific antibodies to Neuropilin 2 implicate VEGF-C and not Semaphorin 3F in breast cancer stem cell function
2020 · Leslie A. Nangle, Luke Burman, et al. · Cancer Research
Works count: 15
Citation count: 124
H-index: 6
I10-index: 5
Year
Topic
Type